With the advent of powerful immunosuppression drugs, acute allograft rejection is rare now in the clinic and the short-term transplant survival hs been excellent. However, long-term transplant survival is also rare and most allografts are continuously lost to rejection as time progresses. It is undeniable that there remain significant barriers to long-term graft acceptance. We recently discovered that Foxp3+ Tregs, a cell type dedicated to immune regulation and critically involved in transplant tolerance, can be driven to """"""""exhaustion"""""""" by a costimulatory molecule OX40. The """"""""exhausted Tregs"""""""" readily lose their regulatory functions, acquire typical exhaustion markers such as PD-1, Tim-3, and KLRG1, and become susceptible to apoptosis. We identified a new transcription factor Baft3 through transcriptional profiling and believed to be involved in Treg exhaustion. Batf3 is strongly induced by OX40 and closely associated with the development of exhausted Tregs. We provide compelling data that Baft3 physically binds to the promoter region of Foxp3 and actively suppresses Foxp3 expression. Based on this, we hypothesized that Treg exhaustion is a preciously unrecognized fate of Foxp3+ Tregs and that Treg exhaustion is transcriptionally regulated in which Batf3 plays a central role. Understanding the mechanisms of Batf3 induction by OX40 and how Batf3 drives Tregs to exhaustion is the central focus of this proposal. We believe that the proposed studies will unravel novel mechanisms of tolerance resistance and may lead to the development of new therapies in the induction of transplant tolerance. In addition, findings from these studies will have broad impact on other immune-mediated diseases, such as cancer therapies, autoimmunity, and vaccination development.
The potential of organ transplantation as a life-saving procedure is limited by drug-associated toxicities and chronic progressive graft loss. Our project is designed to uncover the underlying mechanisms that hinder transplant survival. This line of inquiry will open new therapeutic opportunities in the development of greatly improved therapies for patients with organ transplants as well as treatment of other immune mediated diseases including bone marrow transplantation, autoimmune diabetes, and cancer.
|Zhang, Xiaolong; Xiao, Xiang; Lan, Peixiang et al. (2018) OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms. Cell Rep 24:607-618|
|Xiao, Xiang; Fan, Yihui; Li, Junhui et al. (2018) Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation. J Exp Med 215:559-574|
|Li, Junhui; Chen, Shuqiu; Xiao, Xiang et al. (2017) IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology. Cytokine Growth Factor Rev 37:47-55|
|Wu, Jie; Zhang, Hedong; Shi, Xiaomin et al. (2017) Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction. Immunity 47:1114-1128.e6|
|Lan, Peixiang; Fan, Yihui; Zhao, Yue et al. (2017) TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury. J Clin Invest 127:2222-2234|
|Fischer, Julius Clemens; Otten, Vera; Kober, Maike et al. (2017) A20 Restrains Thymic Regulatory T Cell Development. J Immunol 199:2356-2365|
|Xiao, Xiang; Shi, Xiaomin; Fan, Yihui et al. (2016) The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways. Immunity 44:1271-83|
|Xiao, Xiang; Shi, Xiaomin; Fan, Yihui et al. (2015) GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation. Nat Commun 6:8266|
|Chen, Wenhao; Ghobrial, Rafik M; Li, Xian C (2015) The Evolving Roles of Memory Immune Cells in Transplantation. Transplantation 99:2029-37|